Cleared Traditional

K080926 - AEROECLIPSE DURABLE BREATH ACTUATED NEBULIZER

K080926 is an FDA 510(k) clearance for AEROECLIPSE DURABLE BREATH ACTUATED NEB..., manufactured by Trudell Medical Intl.. The device is a Class 2 Anesthesiology device with product code CAF cleared through the Traditional 510(k) pathway after a 132-day FDA review.

K080926 · Trudell Medical Intl. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2008
Decision
132d
Days
Class 2
Risk

K080926 is an FDA 510(k) clearance for the AEROECLIPSE DURABLE BREATH ACTUATED NEBULIZER. Classified as Nebulizer (direct Patient Interface) (product code CAF), Class II - Special Controls.

Submitted by Trudell Medical Intl. (London, CA). The FDA issued a Cleared decision on August 12, 2008 after a review of 132 days - within the typical 510(k) review window.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5630 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K080926

510(k) Number K080926 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 02, 2008
Decision Date August 12, 2008
Days to Decision 132 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
8d faster than avg
Panel avg: 140d · This submission: 132d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CAF Device Classification - Class 2, Special Controls

Product Code CAF Nebulizer (direct Patient Interface)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5630
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CAF Nebulizer (direct Patient Interface)

All 441
Devices cleared under the same product code (CAF) and FDA review panel - the closest regulatory comparables to K080926.
AERONEB GO NEBULIZER
K081650 · Aerogen (Ireland), Ltd. · Oct 2008
ULTRASONIC NEBULIZER SYSTEM, MODEL HL100
K081738 · Health & Life Co., Ltd. · Sep 2008
HSINER NEBULIZER BOTTLE, CPR MASKS AND FACE SHIELDS
K082009 · Hsiner Co., Ltd. · Aug 2008
HEALTHLINE REDI-NEB MEDICATION NEBULIZER, MODEL RN-510
K080969 · Medi Nuclear Corp., Inc. · Jul 2008
ULTRASONIC NEBULISER MODEL 2010
K072136 · Wilfred Kromker GmbH · Jul 2008
NEB-90 LARGE VOLUME MEDICATION NEBULIZER
K080657 · Medi Nuclear Corp., Inc. · Jun 2008